Biography

Dafni Bika has over 25 years of business and leadership experience in pharmaceutical development and manufacturing science and technology. Dr. Bika has served as Senior Vice President and Global Head of Pharmaceutical Technology and Development at AstraZeneca plc (Nasdaq: AZN) (“AstraZeneca”) since April 2016, where she leads a global team of scientists and engineers in advancing synthetic molecules into approved medicines. Prior to joining AstraZeneca, Dr. Bika held roles of increasing responsibility at Bristol-Myers Squibb Company (NYSE: BMY), serving as Executive Director of Manufacturing Technology, Packaging Technology and Device Operations from September 2009 to July 2012, and as Vice President of Global Drug Product Manufacturing Science and Technology from July 2012 to April 2016. Previously, from April 1999 to August 2009, Dr. Bika served as the Director of Global Pharmaceutical Commercialization at Merck &Co., Inc. (NYSE: MRK). Dr. Bika holds a Ph.D. in Materials Science and Engineering from the University of Pennsylvania, a Master of Science in Materials Science and Engineering from the University of Rochester, NY, and a Diploma in Chemical Engineering from the National Technical University of Athens.